Skip to primary navigation Skip to main content
0 item $0.00

  1. Abrams DJ, Earley MJ, Sporton SC, Kistler PM, Gatzoulis MA, Mullen MJ, Till JA, Cullen S, Walker F, Lowe MD, Deanfield JE, Schilling RJ. Comparison of noncontact and electroanatomic mapping to identify scar and arrhythmia late after the Fontan procedure. Circulation 2007;115(13):1738-46.
  2. ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, Poulter N, Marre M, Cooper M, Glasziou P, Grobbee DE, Hamet P, Heller S, Liu LS, Mancia G, Mogensen CE, Pan CY, Rodgers A, Williams B. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007;370:829-40.
  3. Ahrens I, Peter K, Bode C. Factor Xa-inhibition in interventional cardiology. Hamostaseologie 2007;27(5):328-32.
  4. Ahrens I, Schwarz M, Peter K, Bode C. Therapeutic inhibitors of platelet aggregation - from aspirin to integrin blockers. J Transfus Med Hemother 2007;34(1):44-54.
  5. Ahrens I, Smith BK, Bode C, Peter K. Direct thrombin inhibition with bivalirudin as an antithrombotic strategy in general and interventional cardiology. Expert Opin Drug Metab Toxicol 2007;3(4):609-620.
  6. Ajani AE, Yan BP, Clark DJ, Eccleston D, Walton A, Lew R, Meehan A, Brennan A, Reid C, Duffy SJ; on behalf of the Melbourne Interventional Group (MIG) Investigators. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents. Heart Lung Circ 2007;16(4):269-73.
  7. Alberti KG, Bailey CJ, Blonde L, Felton AM, Zimmet P; Global Partnership for Effective Diabetes Management. Partnering with governments and other institutions: driving change in diabetes care. Int J Clin Pract 2007;Suppl 157:38-46.
  8. Alberti KG, Zimmet P, Shaw J. International Diabetes Federation: a consensus on Type 2 diabetes prevention. Diabet Med 2007;24(5):451-63.
  9. Anstey KJ, Butterworth P, Windsor TD, Burns R, Sargent-Cox K, von Sanden C, Christensen H, Booth H, Simons LA, Byles JE, Gibson R, Luszcz MA, Shaw JE, Broe GA, Browning C, Mitchell P, Cumming RG, Kendig H. The value of comparing health outcomes in cohort studies: an example of self-rated health in seven studies including 79653 participants. Australas J Ageing 2007;26(4):194-200.
  10. Baranyay FJ, Wang Y, Wluka AE, English DR, Giles GG, Sullivan RO, Cicuttini FM. Association of bone marrow lesions with knee structures and risk factors for bone marrow lesions in the knees of clinically healthy, community-based adults. Semin Arthritis Rheum 2007;37(2):112-8.
  11. Barr EL, Zimmet PZ, Welborn TA, Jolley D, Magliano DJ, Dunstan DW, Cameron AJ, Dwyer T, Taylor HR, Tonkin AM, Wong TY, McNeil J, Shaw JE. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 2007;116(2):151-7.
  12. Barton DA, Dawood T, Lambert EA, Esler MD, Haikerwal D, Brenchley C, Socratous F, Kaye DM, Schlaich MP, Hickie I, Lambert GW. Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk? J Hypertens 2007;25(10):2117-24.
  13. Bassler N, Loeffler C, Mangin P, Yuan Y, Schwarz M, Hagemeyer CE, Eisenhardt SU, Ahrens I, Bode C, Jackson SP, Peter K. A mechanistic model for paradoxical platelet activation by ligand-mimetic alphaIIb beta3 (GPIIb/IIIa) antagonists. Arterioscler Thromb Vasc Biol 2007;27(3):e9-15.
  14. Becker AC, Sliwa K, Stewart S, Libhaber E, Essop MR. Acute coronary syndromes in black African patients with human immunodeficiency virus infection : initial results of the clinical and angiographic features. Cardiovasc J Afr 2007;18(3 Suppl):S12-4.
  15. Bernhardt J, Indredavik B, Dewey H, Langhorne P, Lindley R, Donnan G, Thrift A, Collier J. Mobilisation 'in bed' is not mobilisation. Cerebrovasc Dis 2007;24(1):157-8.
  16. Boyko EJ, Magliano D, Shaw JE. Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the Women's Health Initiative Observational Study: response to Song et al. Diabetes Care 2007;30(11):e110.
  17. Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, Collier G, Walder K, Segal D. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 2007;148(10):4687-94.
  18. Bradley SJ, Kingwell BA, Canny BJ, McConell GK. Skeletal muscle neuronal nitric oxide synthase micro protein is reduced in people with impaired glucose homeostasis and is not normalized by exercise training. Metabolism 2007;56(10):1405-11.
  19. Brown A, Brown NJ. The Northern Territory intervention: voices from the centre of the fringe. Med J Aust 2007;187(11-12):621-3.
  20. Brown A, McDonald MI, Calma T. Rheumatic fever and social justice. Med J Aust 2007;186(11):557-8.
  21. Bruce CR, Brolin C, Turner N, Cleasby ME, van der Leij FR, Cooney GJ, Kraegen EW. Overexpression of carnitine palmitoyltransferase I in skeletal muscle in vivo increases fatty acid oxidation and reduces triacylglycerol esterification. Am J Physiol Endocrinol Metab 2007;292(4):E1231-7.
  22. Bruce CR, Febbraio MA. It's what you do with the fat that matters! Nat Med 2007;13(10):1137-8.
  23. Bukrinsky M, Sviridov D. HIV and cardiovascular disease: contribution of HIV-infected macrophages to development of atherosclerosis. PLoS Med 2007;4(1):e43.
  24. Burke SL, Head GA, Lambert GW, Evans RG. Renal sympathetic neuroeffector function in renovascular and angiotensin II-dependent hypertension in rabbits. Hypertension 2007;49(4):932-8.
  25. Burns WC, Kantharidis P, Thomas MC. The role of tubular epithelial-mesenchymal transition in progressive kidney disease. Cells Tissues Organs 2007;185(1-3):222-31.
  26. Cadilhac DA, Carter RC, Thrift AG, Dewey HM. Why invest in a national public health program for stroke? An example using Australian data to estimate the potential benefits and cost implications. Health Policy 2007;83(2-3):287-94.
  27. Calkin AC, Allen TJ, Lassila M, Tikellis C, Jandeleit-Dahm KA, Thomas MC. Increased atherosclerosis following treatment with a dual PPAR agonist in the ApoE knockout mouse. Atherosclerosis 2007;195(1):17-22.
  28. Calkin AC, Jandeleit-Dahm KA, Sebekova E, Allen TJ, Mizrahi J, Cooper ME, Tikellis C. PPARs and diabetes-associated atherosclerosis. Curr Pharm Design 2007;13(26):2736-41.
  29. Cameron AJ, Magliano DJ, Zimmet PZ, Welborn T, Shaw JE. The metabolic syndrome in Australia: prevalence using four definitions. Diabetes Res Clin Pract 2007;77(3):471-8.
  30. Cameron AJ, Zimmet PZ, Soderberg S, Alberti KG, Sicree R, Tuomilehto J, Chitson P, Shaw JE. The metabolic syndrome as a predictor of incident diabetes mellitus in Mauritius. Diabet Med 2007;24(12):1460-9.
  31. Cameron J, Worrall-Carter L, Driscoll A, New G, Stewart S. Extent of heart failure self-care as an endpoint to patient education: a literature review. Br J Card Nursing 2007;2(4):188-97.
  32. Carapetis JR, Brown A, Wilson NJ, Edwards KN. An Australian guideline for rheumatic fever and rheumatic heart disease: an abridged outline. Med J Aust 2007;186(11):581-6.
  33. Champion R, Kinsman LD, Lee GA, Masman KA, May EA, Mills TM, Taylor MD, Thomas PR, Williams RJ. Forecasting emergency department presentations. Aust Health Rev 2007;31(1):83-90.
  34. Chan CK, Burke SL, Head GA. Contribution of imidazoline receptors and alpha2-adrenoceptors in the rostral ventrolateral medulla to sympathetic baroreflex inhibition by systemic rilmenidine. J Hypertens 2007;25(1):147-55.
  35. Chan JC, Deerochanawong C, Shera AS, Yoon KH, Adam JM, Ta VB, Chan SP, Fernando RE, Horn LC, Nguyen TK, Litonjua AD, Soegondo S, Zimmet P. Role of metformin in the initiation of pharmacotherapy for type 2 diabetes: an Asian-Pacific perspective. Diabetes Res Clin Pract 2007;75(3):255-66.
  36. Chaudhry SI, Phillips CO, Stewart SS, Riegel B, Mattera JA, Jerant AF, Krumholz HM. Telemonitoring for patients with chronic heart failure: a systematic review. J Card Fail 2007;13(1):56-62.
  37. Chen L, Peeters A, Magliano DJ, Shaw JE, Welborn TA, Wolfe R, Zimmet PZ, Tonkin AM. Anthropometric measures and absolute cardiovascular risk estimates in the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study. Eur J Cardiovasc Prev Rehabil 2007;14(6):740-5.
  38. Chiam M, Giddy A, Lichter R, Morrison J, Waterkeyn J. Conducting clinical trials in Australia. Monitor 2007;June:51-5.
  39. Chin-Dusting JPF, Willems L, Kaye DM. L-arginine transporters in cardiovascular disease: a novel therapeutic target. Pharmacol Ther 2007;116(3):428-36.
  40. Chitravas N, Dewey HM, Nicol MB, Harding DL, Pearce DC, Thrift AG. Is prestroke use of angiotensin-converting enzyme inhibitors associated with better outcome? Neurology 2007;68(20):1687-93.
  41. Clark RA, Driscoll A, Nottage J, McLennan S, Coombe DM, Bamford EJ, Wilkinson D, Stewart S. Inequitable provision of optimal services for patients with chronic heart failure: a national geo-mapping study. Med J Aust 2007;186(4):169-73.
  42. Clark RA, Eckert KA, Stewart S, Phillips SM, Yallop JJ, Tonkin AM, Krum H. Rural and urban differentials in primary care management of chronic heart failure: new data from the CASE study. Med J Aust 2007;186(9):441-5.
  43. Clark RA, Inglis SC, McAlister FA, Cleland JG, Stewart S. Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis. BMJ 2007;334(7600):942-50.
  44. Clark RA, Yallop JJ, Piterman L, Croucher J, Tonkin A, Stewart S, Krum H; on behalf of the CHAT Study Team. Adherence, adaptation and acceptance of elderly chronic heart failure patients to receiving healthcare via telephone-monitoring. Eur J Heart Fail 2007;9(11):1104-11.
  45. Coffey VG, Reeder DW, Lancaster GI, Yeo WK, Febbraio MA, Yaspelkis BB 3rd, Hawley JA. Effect of high-frequency resistance exercise on adaptive responses in skeletal muscle. Med Sci Sports Exerc 2007;39(12):2135-44.
  46. Cohen N, Minshall ME, Sharon-Nash L, Zakrzewska K, Valentine WJ, Palmer AJ. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin: economic comparison in adult and adolescent Type 1 diabetes mellitus in Australia. Pharmacoeconomics 2007;25(10):881-97.
  47. Cohen N, Shaw J. Cost effectiveness of insulin pump therapy. Infusystems Int 2007;2(4):25-8.
  48. Cohen N. Insulin pump therapy. Med Today 2007;8(11):68-70.
  49. Cohen ND, Shaw JE. Diabetes: advances in treatment. Intern Med J 2007;37(6):383-8.
  50. Coughlan MT, Cooper ME, Forbes JM. Renal microvascular injury in diabetes: RAGE and redox signaling. Antioxid Redox Signal 2007;9(3):331-42.
  51. Coughlan MT, Cooper ME, Thomas MC. Can you reduce your AGEs? Strategies to prevent AGE accumulation in diabetes. Drug Discovery Today: Therapeutic Strategies 2007;4(1):85-92.
  52. Coughlan MT, Forbes JM, Cooper ME. Role of the AGE crosslink breaker, alagebrium, as a renoprotective agent in diabetes. Kidney Int 2007;72(106):S54-60.
  53. Coughlan MT, Thallas-Bonke V, Pete J, Long DM, Gasser A, Tong DC, Arnstein M, Thorpe SR, Cooper ME, Forbes JM. Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy? Endocrinology 2007;148(2):886-95.
  54. Curran JE, Johnson MP, Dyer TD, Goring HH, Kent JW, Charlesworth JC, Borg AJ, Jowett JB, Cole SA, MacCluer JW, Kissebah AH, Moses EK, Blangero J. Genetic determinants of mitochondrial content. Hum Mol Genet 2007;16(12):1504-14.
  55. Dart AM, Cameron JD, Gatzka C, Kingwell BA, Jennings GLR. Response to effects of angiotensin-converting enzyme inhibitors on central blood pressure. Hypertension 2007;50(3):e63. Letter.
  56. Dart AM, Cameron JD, Gatzka CD, Willson K, Liang Y-L, Berry KL, Wing LMH, Reid CM, Ryan P, Beilin LJ, Jennings GLR, Johnston CI, McNeil JJ, MacDonald GJ, Morgan TO, West MJ, Kingwell BA. Similar effects of treatment on central and brachial blood pressures in older hypertensive subjects in the Second Australian National Blood Pressure Trial. Hypertension 2007;49(6):1242-7.
  57. Dart AM, Otterstad JE, Kirwan BA, Parker JD, de Brouwer S, Poole-Wilson PA, Lubsen J, on behalf of the ACTION investigators. Predictive value of local and core laboratory echocardiographic assessment of cardiac function in patients with chronic stable angina: the ACTION study. Eur J Echocardiogr 2007;8(4):275-83.
  58. Davern PJ, Head GA. Fos-related antigen immunoreactivity after acute and chronic angiotensin II-induced hypertension in the rabbit brain. Hypertension 2007;9(5):1170-7.
  59. Dawood T, Anderson J, Barton D, Lambert E, Esler M, Hotchkin E, Haikerwal D, Kaye, D, Lambert G. Reduced overflow of BDNF from the brain is linked with suicide risk in depressive illness. Mol Psychiatr 2007;12(11):981-3.
  60. Dawood T, Lambert EA, Barton DA, Laude D, Elghozi J-L, Esler MD, Haikerwal H, Kaye DM, Hotchkin EJ, Lambert GW. Specific serotonin reuptake inhibition in major depressive disorder adversely affects novel markers of cardiac risk. Hypertens Res 2007;30(4):285-93.
  61. Dawson AP, McLennan SN, Schiller SD, Jull GA, Hodges PW, Stewart S. Interventions to prevent back pain and back injury in nurses: a systematic review. Occup Environ Med 2007;64(10):642-50.
  62. de Dios ST, Frontanilla KV, Nigro J, Ballinger ML, Ivey ME, Cawson EA, Little PJ. Regulation of the atherogenic properties of vascular smooth muscle proteoglycans by oral anti-hyperglycemic agents. J Diabetes Complicat 2007;21(2):108-17.
  63. Del Prato S, Felton AM, Munro N, Nesto R, Zimmet P, Zinman B; Global Partnership for Effective Diabetes Management. Improving glucose management: ten steps to get more patients with Type 2 diabetes to glycaemic goal. Recommendations from the Global Partnership for Effective Diabetes Management. Int J Clin Pract 2007;Suppl 157:47-57.
  64. Desai M, Cull CA, Horton VA, Christie MR, Bonifacio E, Lampasona V, Bingley PJ, Levy JC, Mackay IR, Zimmet P, Holman RR, Clark A. GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77. Diabetologia 2007;50(10):2052-60.
  65. Di Quinzio MK, Oliva K, Holdsworth SJ, Ayhan M, Walker SP, Rice GE, Georgiou HM, Permezel M. Proteomic analysis and characterisation of human cervico-vaginal fluid proteins. Aust NZ J Obstet Gynaecol 2007;47(1):9-15.
  66. Diego VP, Rainwater DL, Wang XL, Cole SA, Curran JE, Johnson MP, Jowett JB, Dyer TD, Williams JT, Moses EK, Comuzzie AG, Maccluer JW, Mahaney MC, Blangero J. Genotype x adiposity interaction linkage analyses reveal a locus on chromosome 1 for lipoprotein-associated phospholipase A2, a marker of inflammation and oxidative stress. Am J Hum Genet 2007;80(1):168-77.
  67. Drew BG, Calkin AC. Drug evaluation: K-111, an insulin-sensitizing peroxisome proliferator-activated receptor alpha agonist. Curr Opin Investig Drugs 2007;8(4):324-30.
    Du XJ. Divergence of hypertrophic growth and fetal gene profile: the influence of beta-blockers. Br J Pharmacol 2007;152(2):169-71.
  68. Du XJ. Re-modelling 'hostile' milieu of diseased myocardium via paracrine function of transplanted cells or relaxin. J Cell Mol Med 2007;11(5):1101-4.
  69. Du XJ, Zhou J. Role of relaxin in heart disease and therapeutic potential. J Xian Jiaotong University (Med Sci) 2007;28:117-26.
  70. Dunstan DW, Salmon J, Healy GN, Shaw JE, Jolley D, Zimmet PZ, Owen N; AusDiab Steering Committee. Association of television viewing with fasting and 2-h postchallenge plasma glucose levels in adults without diagnosed diabetes. Diabetes Care 2007;30(3):516-22.
  71. Dwyer T, Hosmer D, Hosmer T, Venn AJ, Blizzard CL, Granger RH, Cochrane JA, Blair SN, Shaw JE, Zimmet PZ, Dunstan D. The inverse relationship between number of steps per day and obesity in a population-based sample: the AusDiab study. Int J Obes 2007;31(5):797-804.
  72. Eichenauer DA, Simhadri VL, von Strandmann EP, Ludwig A, Matthews V, Reiners KS, von Tresckow B, Saftig P, Rose-John S, Engert A, Hansen HP. ADAM10 inhibition of human CD30 shedding increases specificity of targeted immunotherapy in vitro. Cancer Res 2007;67(1):332-8.
  73. Eijkelkamp WB, Zhang Z, Brenner BM, Cooper ME, Devereux RB, Dahlof B, Ibsen H, Keane WF, Lindholm LH, Olsen MH, Parving HH, Remuzzi G, Shahinfar S, Snapinn SM, Wachtell K, de Zeeuw D. Renal function and risk for cardiovascular events in Type 2 diabetic patients with hypertension: the RENAAL and LIFE studies. J Hypertens 2007;25(4):871-6.
  74. Eijkelkamp WB, Zhang Z, Remuzzi G, Parving HH, Cooper ME, Keane WF, Shahinfar S, Gleim GW, Weir MR, Brenner BM, de Zeeuw D. Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with Type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial. J Am Soc Nephrol 2007;18(5):1540-6.
  75. Eikelis N, Wiesner G, Lambert G, Esler M. Brain leptin resistance in human obesity revisited. Regul Pept 2007;139(1-3):45-51.
  76. Eisenhardt SU, Schwarz M, Bassler N, Peter K. Subtractive single-chain antibody (scFv) phage-display: tailoring phage-display for high specificity against function-specific conformations of cell membrane molecules. Nat Protoc 2007;2(12):3063-73.
  77. Eisenhardt SU, Schwarz M, Schallner N, Soosairajah J, Bassler N, Huang D, Bode C, Peter K. Generation of activation-specific human anti-alphaMbeta2 single-chain antibodies as potential diagnostic tools and therapeutic agents. Blood 2007;109(8):3521-8.
  78. Elliott P, Walker LL, Little MP, Blair-West JR, Shade RE, Lee DR, Rouquet P, Leroy E, Jeunemaitre X, Ardaillou R, Paillard F, Meneton P, Denton DA. Change in salt intake affects blood pressure of chimpanzees: implications for human populations. Circulation 2007;116(14):1563-8.
  79. Esler M, Lambert E, Alvarenga M, Socratous F, Richards R, Barton D, Pier C, Brenchley C, Dawood T, Hastings J, Guo L, Haikerwal D, Kaye D, Jennings G, Kalff V, Kelly M, Wiesner G, Lambert G. Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: reduction by a selective serotonin reuptake inhibitor. Stress 2007;10(3):295-304.
  80. Esler M, Lambert E. Hypertension, SNS overactivity and the brain: interactions with peripheral organs - psychological influences and stress and target organ damage. Dialog Cardiovasc Med 2007;12:183-91.
  81. Esler M, Schwarz R. Management of hypertension complicated by psychiatric comorbidity. J Clin Hypertens 2007;9(9):708-13.
  82. Evans RG, Burke SL, Lambert GW, Head GA. Renal responses to acute reflex activation of renal sympathetic nerve activity and renal denervation in secondary hypertension. Am J Physiol Regul Integr Comp Physiol 2007;293(3):R1247-56.
  83. Fang L, Gao XM, Moore XL, Kiriazis H, Su Y, Ming Z, Lim YL, Dart AM, Du XJ. Differences in inflammation, MMP activation and collagen damage account for gender difference in murine cardiac rupture following myocardial infarction. J Mol Cell Cardiol 2007;43(5):535-44.
  84. Fang L, Moore XL, Gao XM, Dart AM, Lim YL, Du XJ. Down-regulation of mitofusin-2 expression in cardiac hypertrophy in vitro and in vivo. Life Sci 2007;80(23):2154-60.
  85. Febbraio MA. Exercise and inflammation. J Appl Physiol 2007;103(1):376-7.
  86. Febbraio MA. gp130 receptor ligands as potential therapeutic targets for obesity. J Clin Invest 2007;117(4):841-9.
  87. Fitzgerald SM, Bashari H, Cox JA, Parkington HC, Evans RG. Contributions of endothelium-derived relaxing factors to control of hindlimb blood flow in the mouse in vivo. Am J Physiol Heart Circul Physiol 2007;293(2):H1072-82.
  88. Fitzgerald SM, Kemp-Harper BK, Parkington HC, Head GA, Evans RG. Endothelial dysfunction and arterial pressure regulation during early diabetes in mice: roles for nitric oxide and endothelium-derived hyperpolarizing factor. Am J Physiol Regul Integr Comp Physiol 2007;293(2):R707-13.
  89. Forbes JM, Cooper ME. The role of mitochondrial dysfunction in diabetic complications. Int Diabetes Monitor 2007;19(6):9-15.
  90. Forbes JM, Fukami K, Cooper ME. Diabetic nephropathy: where hemodynamics meets metabolism. Exp Clin Endocrinol Diabetes 2007;115(2):69-84.
  91. Fujii A, Allen TJ, Nestel PJ. A 1,3-diacylglycerol-rich oil induces less atherosclerosis and lowers plasma cholesterol in diabetic apoE-deficient mice. Atherosclerosis 2007;193(1):55-61.
  92. Gao J, Chang Chua C, Chen Z, Wang H, Xu X, Hamdy RC, McMullen JR, Shioi T, Izumo S, Chua BH. Resistin, an adipocytokine, offers protection against acute myocardial infarction. J Mol Cell Cardiol 2007;43(5):601-9.
  93. Gao Y, Pagnon J, Feng HC, Konstantopolous N, Jowett JB, Walder K, Collier GR. Secretion of the glucose-regulated selenoprotein SEPS1 from hepatoma cells. Biochem Biophys Res Commun 2007;356(3):636-41.
  94. Garbrecht MR, Klein JM, McCarthy TA, Schmidt TJ, Krozowski ZS, Snyder JM. 11- Hydroxysteroid dehydrogenase type 2 in human adult and fetal lung and its regulation by sex steroids. Pediatr Res 2007;62(1):26-31.
  95. Gaynor L, Gallasch T, Yorkston E, Stewart S, Bogossian F, Fairweather C, Foley D, Nutter H, Thompson J, Stewart L, Anastasi J, Kelly J, Barnes L, Glover P, Turner C. The future nursing workforce in Australia: baseline data for a prospective study of the profile, attrition rates and graduate outcomes in a contemporary cohort of undergraduates. Aust J Adv Nurs 2007;25(2):11-20.
  96. Gaynor L, Gallasch T, Yorkston E, Stewart S, Turner C. Where do all the undergraduate and new graduate nurses go and why? A search for empirical research evidence. J Adv Nurs 2007;24(2):26-32.
  97. Goh SS, Woodman OL, Pepe S, Cao AH, Qin C, Ritchie RH. The red wine antioxidant resveratrol prevents cardiomyocyte injury following ischemia-reperfusion via multiple sites and mechanisms. Antioxid Redox Signal 2007;9(1):101-13.
  98. Göring HH, Curran JE, Johnson MP, Dyer TD, Charlesworth J, Cole SA, Jowett JB, Abraham LJ, Rainwater DL, Comuzzie AG, Mahaney MC, Almasy L, Maccluer JW, Kissebah AH, Collier GR, Moses EK, Blangero J. Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes. Nat Genet 2007;39(10):1208-16.
  99. Gould PA, Kong G, Kalff V, Duffy SJ, Taylor AJ, Kelly MJ, Kaye DM. Improvement in cardiac adrenergic function post biventricular pacing for heart failure. Europace 2007;9(9):751-6.
  100. Grande-Allen KJ, Osman N, Ballinger M, Dadlani H, Marasco S, Little PJ. Glycosaminoglycan synthesis and structure as targets for the prevention of calcific aortic valve disease. Cardiovasc Res 2007;76(1):19-28.
  101. Groop PH, Thomas MC, Rosengard-Barlund M, Mills V, Ronnback M, Thomas S, Forsblom C, Taskinen MR, Viberti G. HDL composition predicts new-onset cardiovascular disease in patients with Type 1 diabetes. Diabetes Care 2007;30(10):2706-7.
  102. Guymer E, Baranyay F, Wluka AE, Hanna F, Bell RJ, Davis SR, Wang Y, Cicuttini FM. A study of the prevalence and associations of subchondral bone marrow lesions in the knees of healthy, middle-aged women. Osteoarthritis Cartilage 2007;15(12):1437-42.
  103. Hagemeyer CE, Schwarz M, Peter K. Single-chain antibodies as new antithrombotic drugs. Semin Thromb Hemost 2007;33(2):185-95.
  104. Hamming I, Cooper ME, Haagmans BL, Hooper NM, Korstanje R, Osterhaus AD, Timens W, Turner AJ, Navis G, van Goor H. The emerging role of ACE2 in physiology and disease. J Pathol 2007;212(1):1-11.
  105. Hanna FS, Bell RJ, Cicuttini FM, Davison SL, Wluka AE, Davis SR. The relationship between endogenous testosterone, preandrogens, and sex hormone binding globulin and knee joint structure in women at midlife. Semin Arthritis Rheum 2007;37(1):56-62.
  106. Hanna FS, Bell RJ, Davis SR, Wluka AE, Teichtahl AJ, O'Sullivan R, Cicuttini FM. Factors affecting patella cartilage and bone in middle-aged women. Arthritis Rheum 2007;57(2):272-8.
  107. Harazny JM, Ritt M, Baleanu D, Ott C, Heckmann J, Schlaich MP, Michelson G, Schmieder RE. Increased wall:lumen ratio of retinal arterioles in male patients with a history of a cerebrovascular event. Hypertension 2007;50(4):623-9.
  108. Healy GN, Dunstan DW, Salmon J, Cerin E, Shaw JE, Zimmet PZ, Owen N. Objectively measured light-intensity physical activity is independently associated with 2-h plasma glucose. Diabetes Care 2007;30(6):1384-9.
  109. Hein LK, Meikle PJ, Hopwood JJ, Fuller M. Secondary sphingolipid accumulation in a macrophage model of Gaucher disease. Mol Genet Metab 2007;92(4):336-345.
  110. Hevener AL, Olefsky JM, Reichart D, Nguyen MT, Bandyopadyhay G, Leung HY, Watt MJ, Benner C, Febbraio MA, Nguyen AK, Folian B, Subramaniam S, Gonzalez FJ, Glass CK, Ricote M. Macrophage PPARgamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. J Clin Invest 2007;117(6):1658-69.
  111. Hoang A, Murphy AJ, Coughlan MT, Thomas MC, Forbes JM, O'Brien R, Cooper ME, Chin-Dusting JP, Sviridov D. Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties. Diabetologia 2007;50(8):1770-9.
  112. Hoppe CC, Evans RG, Moritz KM, Cullen-McEwen LA, Fitzgerald SM, Dowling J, Bertram JF. Combined prenatal and postnatal protein restriction influences adult kidney structure, function, and arterial pressure. Am J Physiol Regul Integr Comp Physiol 2007;292(1):R462-9.
  113. Hoy AJ, Bruce CR, Cederberg A, Turner N, James DE, Cooney GJ, Kraegen EW. Glucose infusion causes insulin resistance in skeletal muscle of rats without changes in Akt and AS160 phosphorylation. Am J Physiol Endocrinol Metab 2007;293(5):E1358-64.
  114. Hoy WE, Kondalsamy-Chennakesavan S, Wang Z, Briganti E, Shaw J, Polkinghorne K, Chadban S; AusDiab Study Group. Quantifying the excess risk for proteinuria, hypertension and diabetes in Australian Aborigines: comparison of profiles in three remote communities in the Northern Territory with those in the AusDiab study. Aust NZ J Public Health 2007;31(2):177-83.
  115. Inglis SC, Stewart S, Papachan A, Vaghela V, Libhaber C, Veriava Y, Sliwa K. Anaemia and renal function in heart failure due to idiopathic dilated cardiomyopathy. Eur J Heart Fail 2007;9(4):384-90.
  116. Jackson K, Head GA, Morris BJ, Chin-Dusting J, Jones E, La Greca L, Mayorov DN. Reduced cardiovascular reactivity to stress but not feeding in renin enhancer knockout mice. Am J Hypertens 2007;20(8):893-9.
  117. Jackson SP, Calkin AC. The clot thickens--oxidized lipids and thrombosis. Nat Med 2007;13(9):1015-6.
  118. Jang C, Obeyesekere VR, Dilley RJ, Krozowski Z, Inder WJ, Alford FP. Altered activity of 11beta hydroxysteroid dehydrogenase type 1 and 2 in skeletal muscle confers metabolic protection in subjects with Type 2 diabetes. J Clin Endocrinol Metab 2007;92(8):3314-20.
  119. Jennings GLR, McMullen JR. Left ventricular hypertrophy: beyond the image and defining the human cardiac phenotype in hypertension. J Hypertens 2007;25(5):941-7.
  120. Jiang XY, Gao GD, Du XJ, Zhou J, Wang XF, Lin YX. The signalling of AT2 and the influence on the collagen metabolism of AT2 receptor in adult rat cardiac fibroblasts. Acta Cardiol 2007;62(5):429-38.
  121. Johnson MP, Fitzpatrick E, Dyer TD, Jowett JB, Brennecke SP, Blangero J, Moses EK. Identification of two novel quantitative trait loci for pre-eclampsia susceptibility on chromosomes 5q and 13q using a variance components-based linkage approach. J Mol Hum Reprod 2007;13(1):61-7.
  122. Kalman JM, Kistler PM, Waldo AL. Localization of focal atrial tachycardias--back to the future...when (old) electrophysiologic first principles complement sophisticated technology. J Cardiovasc Electrophysiol 2007;18(1):7-8.
  123. Karagiannis TC, El-Osta A. Chromatin modifications and DNA double-strand breaks: the current state of play. Leukemia 2007;21(2):195-200.
  124. Karagiannis TC, El-Osta A. Will broad-spectrum histone deacetylase inhibitors be superseded by more specific compounds? Leukemia 2007;21(1):61-5.
  125. Karagiannis TC, Harikrishnan KN, El-Osta A. Disparity of histone deacetylase inhibition on repair of radiation-induced DNA damage on euchromatin and constitutive heterochromatin compartments. Oncogene 2007;26(27):3963-71.
  126. Kaufman FR, Shaw J. Type 2 diabetes in youth: rates, antecedents, treatment, problems and prevention. Pediatr Diabetes 2007;8 Suppl 9:4-6.
  127. Kaye DM, Krum H. Drug discovery for heart failure: a new era or the end of the pipeline? Nat Rev Drug Discov 2007;6(2):127-39.
  128. Kaye DM, Preovolos A, Marshall T, Byrne M, Hoshijima M, Hajjar R, Mariani JA, Pepe S, Chien KR, Power JM. Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals. J Am Coll Cardiol 2007;50(3):253-60.
  129. Khan R, Agrotis A, Bobik A. Understanding the role of transforming growth factor-1 in intimal thickening after vascular injury. Cardiovasc Res 2007;74(2):223-34.
  130. Kingwell B, Boutouyrie P. Genetic influences on the arterial wall. Clin Exp Pharmacol Physiol 2007;34(7):652-7.
  131. Kingwell BA, Ahimastos AA. Arterial stiffness and coronary ischemic disease. Adv Cardiol 2007;44:125-38.
  132. Kirkman S, Thompson DR, Watson R, Stewart S. Are all doctorates equal or are some "more equal than others"?: an examination of which ones should be offered by schools of nursing. Nurse Educ Pract 2007;7(2):61-6.
  133. Kistler PM, Habersberger J. Management of atrial fibrillation. Aust Fam Physician 2007;36(7):506-8,511.
  134. Kistler PM, Ho SY, Rajappan K, Morper M, Harris S, Abrams D, Sporton SC, Schilling RJ. Electrophysiologic and anatomic characterization of sites resistant to electrical isolation during circumferential pulmonary vein ablation for atrial fibrillation: a prospective study. J Cardiovasc Electrophysiol 2007;18(12):1282-8.
  135. Kistler PM, Obeyesekere MN. Pharmacologic management of tachycardia. Aust Fam Physician 2007;36(7):500-5.
  136. Kistler PM, Schilling RJ, Rajappan K, Sporton SC. Image integration for atrial fibrillation ablation--pearls and pitfalls. Heart Rhythm 2007;4(9):1216-21.
  137. Kistler PM. Catheter ablation techniques in managing arrhythmias. Aust Fam Physician 2007;36(7):512-7.
  138. Kistler PM. The left atrial appendage: not just an innocent bystander. J Cardiovasc Electrophysiol 2007;18(5):465-6.
  139. Knight B, Akhurst B, Matthews VB, Ruddell RG, Ramm GA, Abraham LJ, Olynyk JK, Yeoh GC. Attenuated liver progenitor (oval) cell and fibrogenic responses to the choline deficient, ethionine supplemented diet in the BALB/c inbred strain of mice. J Hepatol 2007;46(1):134-41.
  140. Konstantakopoulos N, Larsen MR, Campbell IG, Quinn MA, Baker MS, Georgiou HM, Rice GE. Genistein induces proteomic changes in the human endometrial carcinoma cell line, Ishikawa. Clin Proteomics 2007;2:153-67.
  141. Kulkarni S, Woollard KJ, Thomas S, Oxley D, Jackson SP. Conversion of platelets from a proaggregatory to a proinflammatory adhesive phenotype: role of PAF in spatially regulating neutrophil adhesion and spreading. Blood 2007;110(6):1879-86.
  142. Lambers Heerspink HJ, Fowler MJ, Volgi J, Reutens AT, Klein I, Herskovits TA, Packham DK, Fraser IR, Schwartz SL, Abaterusso C, Lewis J; Collaborative Study Group. Rationale for and study design of the sulodexide trials in Type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy. Diabet Med 2007;24(11):1290-5.
  143. Lambert E, Dawood T, Esler M, Barton D, Eikelis N, Bayles R, Lambert G. Psychological stress and the development of heart disease. Curr Psych Rev 2007;3(4):252-8.
  144. Lambert E, Straznicky N, Eikelis N, Esler M, Dawood T, Masuo K, Schlaich M, Lambert G. Gender differences in sympathetic nervous activity: influence of body mass and blood pressure. J Hypertens 2007;25(7):1411-9.
  145. Lambert E, Straznicky N, Schlaich M, Esler M, Dawood T, Hotchkin E, Lambert G. Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension. Hypertension 2007;50(5):862-8.
  146. Lambert GW, Schlaich MP, Esler MD. Brain derived neurotrophic factor (BDNF) release from the human brain in patients with Type 2 diabetes-possible influence of venous anatomy and comorbid major depressive disorder. Diabetologia 2007;50(9):2027-8.
  147. Lappas M, Permezel M, Holdsworth SJ, Zanoni G, Porta A, Rice GE. Antiinflammatory effects of the cyclopentenone isoprostane 15-A2-IsoP in human gestational tissues. Free Radic Biol Med 2007;42(12):1791-6.
  148. Lappas M, Permezel M, Rice GE. Advanced glycation endproducts mediate pro-inflammatory actions in human gestational tissues via nuclear factor-kappaB and extracellular signal-regulated kinase 1/2. J Endocrinol 2007;193(2):269-77.
  149. Lappas M, Permezel M, Rice GE. Mitogen-activated protein kinase proteins regulate LPS-stimulated release of pro-inflammatory cytokines and prostaglandins from human gestational tissues. Placenta 2007;28(8-9):936-45.
  150. Lappas M, Rice GE. The role and regulation of the nuclear factor kappa B signalling pathway in human labour. Placenta 2007;28(5-6):543-56.
  151. Lassila M, Fukami K, Jandeleit-Dahm K, Semple T, Carmeliet P, Cooper ME, Kitching AR. Plasminogen activator inhibitor-1 production is pathogenetic in experimental murine diabetic renal disease. Diabetologia 2007;50(6):1315-26.
  152. Lee G, Carrington M. Tackling heart disease and poverty. Nurs Health Sci 2007;9(4):290-4.
  153. Lessard SJ, Rivas DA, Chen ZP, Bonen A, Febbraio MA, Reeder DW, Kemp BE, Yaspelkis BB 3rd, Hawley JA. Tissue-specific effects of rosiglitazone and exercise in the treatment of lipid-induced insulin resistance. Diabetes 2007;56(7):1856-64.
  154. Lewis P, Stefanovic N, Pete J, Calkin AC, Giunti S, Thallas-Bonke V, Jandeleit-Dahm KA, Allen TJ, Kola I, Cooper ME, de Haan JB. Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice. Circulation 2007;115(16):2178-87.
  155. Liew R, Rajappan K, Gupta D, Kistler P, Schilling R. Percutaneous epicardial ablation reverses ventricular tachycardia mediated cardiomyopathy. J Interv Card Electrophysiol 2007;18(3):265-7.
  156. Lim HK, Anderson J, Leong JY, Pepe S, Salamonsen RF, Rosenfeldt FL. What is the role of leukocyte depletion in cardiac surgery? Heart Lung Circ 2007;16(4):243-53.
  157. Lim K, Salamonsen R, Anderson J, Pepe S, Leong JY, Rosenfeldt F. Response to letter to the editor. Heart Lung Circ 2007;16(5):399-400.
  158. Lim R, Ahmed N, Borregaard N, Riley C, Wafai R, Thompson EW, Quinn MA, Rice GE. Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition. Int J Cancer 2007;120(11):2426-34.
  159. Little PJ, Ballinger ML, Osman N. Vascular wall proteoglycan synthesis and structure as a target for the prevention of atherosclerosis. Vasc Health Risk Manag 2007;3(1):117-24.
  160. Little PJ, Osman N, de Dios ST, Cemerlang N, Ballinger M, Nigro J. Anti-proliferative activity of oral anti hyperglycemic agents on human vascular smooth muscle cells: thiazolidinediones (glitazones) have enhanced activity under high glucose conditions. Cardiovasc Diabetol 2007;6(1):33.
  161. MacIsaac RJ, Tsalamandris C, Thomas MC, Premaratne E, Panagiotopoulos S, Smith TJ, Poon A, Jenkins MA, Ratnaike SI, Power DA, Jerums G. The accuracy of cystatin C and commonly used creatinine-based methods for detecting moderate and mild chronic kidney disease in diabetes. Diabet Med 2007;24(4):443-8.
  162. Maduwegedera D, Kett MM, Flower RL, Lambert GW, Bertram JF, Wintour EM, Denton KM. Sex differences in postnatal growth and renal development in offspring of rabbit mothers with chronic secondary hypertension. Am J Physiol Regul Integr Comp Physiol 2007;292(2):R706-14.
  163. Magliano DJ, Polkinghorne KR, Barr EL, Su Q, Chadban SJ, Zimmet PZ, Shaw JE, Atkins RC. HPLC-detected albuminuria predicts mortality. J Am Soc Nephrol 2007;18(12):3171-6.
  164. Mancia G, Bousquet P, Elghozi JL, Esler M, Grassi G, Julius S, Reid J, Van Zwieten PA. The sympathetic nervous system and the metabolic syndrome. J Hypertens 2007;25(5):909-20.
  165. Maple-Brown L, Cunningham J, Celermajer DS, O'Dea K. Increased carotid intima-media thickness in remote and urban Indigenous Australians: impact of diabetes and components of the metabolic syndrome. Clin Endocrinol 2007;66(3):419-25.
  166. Maple-Brown LJ, Piers LS, O'Rourke MF, Celermajer DS, O'Dea K. Increased arterial stiffness in remote Indigenous Australians with high risk of cardiovascular disease. J Hypertens 2007;25(3):585-91.
  167. Marasco SF, Esmore DS, Richardson M, Bailey M, Negri J, Rowland M, Kaye D, Bergin PJ. Prolonged cardiac allograft ischemic time--no impact on long-term survival but at what cost? Clin Transplant 2007;21(3):321-9.
  168. Masuo K, Katsuya T, Sugimoto K, Kawaguchi H, Rakugi H, Ogihara T, Tuck ML. High plasma norepinephrine levels associated with beta2-adrenoceptor polymorphisms predict future renal damage in nonobese normotensive individuals. Hypertens Res 2007;30(6):503-11.
  169. Mayorov DN. Brain angiotensin and cardiovascular reactivity to negative and positive emotional stress. Curr Hypertens Rev 2007;3(2):105-17.
  170. Mayorov DN. Brain superoxide as a key regulator of the cardiovascular response to emotional stress in rabbits. Exp Physiol 2007;92(3):471-9.
  171. Mayorov DN. ERK1/2 as a molecular switch for the initiation of long-term pressor response to central angiotensin II. J Hypertens 2007;25(9):1788-90.
  172. Mayorov DN. Nitric oxide synthase inhibition in rostral ventrolateral medulla attenuates pressor response to psychological stress in rabbits. Neurosci Lett 2007;424(2):89-93.
  173. McConell GK, Bradley SJ, Stephens TJ, Canny BJ, Kingwell BA, Lee-Young RS. Skeletal muscle nNOS protein content is increased by exercise training in humans. Am J Physiol Endocrinol Metab 2007;293(2):R821-8.
  174. McDonald M, Brown A, Edwards T, Hope A, Amu M, Morey F, Currie BJ, Carapetis JR. Apparent contrasting rates of pharyngitis and pyoderma in regions where rheumatic heart disease is highly prevalent. Heart Lung Circ 2007;16(4):254-9.
  175. McMullen JR, Amirahmadi F, Woodcock EA, Schinke-Braun M, Bouwman RD, Hewitt KA, Mollica JP, Zhang L, Zhang Y, Shioi T, Buerger A, Izumo S, Jay PY, Jennings GL. Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy. Proc Natl Acad Sci USA 2007;104(2):612-7.
  176. McMullen JR, Jay PY. PI3K(p110alpha) inhibitors as anti-cancer agents: minding the heart. Cell Cycle 2007;6(8):910-3.
  177. McMullen JR, Jennings GL. Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure. Clin Exp Pharmacol Physiol 2007;34(4):255-62.
  178. Meadows GN, Harvey CA, Joubert L, Barton D, Bedi G. Best practices: the consultation-liaison in primary-care psychiatry program: a structured approach to long-term collaboration. Psychiatr Serv 2007;58(8):1036-8.
  179. Mischak H, Apweiler R, Banks RE, Conaway M, Coon J, Dominiczak A, Ehrich JH, Fliser D, Girolami M, Hermjakob H, Hochstrasser D, Jankowski J, Julian BA, Kolch W, Massy ZA, Neusuess C, Novak J, Peter K, Rossing K, Schanstra J, Semmes OJ, Theodorescu D, Thongboonkerd V, Weissinger EM, Van Eyk JE, Yamamoto T. Clinical proteomics: A need to define the field and to begin to set adequate standards. Proteomics Clin Appl 2007;1(2):148-56. 
  180. Moore XL, Tan SL, Lo CY, Fang L, Su YD, Gao XM, Woodcock EA, Summers RJ, Tregear GW, Bathgate RA, Du XJ. Relaxin antagonizes hypertrophy and apoptosis in neonatal rat cardiomyocytes. Endocrinology 2007;148(4):1582-9.
  181. Mukhamedova N, Fu Y, Bukrinsky M, Remaley AT, Sviridov D. The role of different regions of ATP-binding cassette transporter A1 in cholesterol efflux. Biochemistry 2007;46(33):9388-98.
  182. Murphy A, White A, Nair R, Kingwell B, Duffy S, Chin-Dusting J, Woollard K. C-reactive protein and FcRIIa functional polymorphisms are not associated with clinical presentation of stable and unstable angina. Thromb Haemost 2007;97(4):681-2.
  183. Murphy NF, Simpson CR, Jhund PS, Stewart S, Kirkpatrick M, Chalmers J, MacIntyre K, McMurray JJV. A national survey of the prevalence, incidence and primary care burden and treatment of atrial fibrillation in Scotland. Heart 2007;93(5):606-12.
  184. Naredi S, Lambert G, Friberg P. Authors' reply to the comment by Kox et al. Intensive Care Med 2007;33(7):1304.
  185. Nestel P, Fujii A, Zhang L. An isoflavone metabolite reduces arterial stiffness and blood pressure in overweight men and postmenopausal women. Atherosclerosis 2007;192(1):184-9.
  186. Nestel P, Lyu R, Low LP, Sheu WH, Nitiyanant W, Saito I, Tan CE. Metabolic syndrome: recent prevalence in East and Southeast Asian populations. Asia Pac J Clin Nutr 2007;16(2):362-7.
  187. Nestel P. Nutritional evidence still lacks consistency. Curr Opin Lipidol 2007;18(1):1-2.
  188. Nielsen HB, Febbraio MA, Ott P, Krustrup P, Secher NH. Hepatic lactate uptake versus leg lactate output during exercise in humans. J Appl Physiol 2007;103(4):1227-33.
  189. Obesity in Asia Collaboration, Huxley R, Barzi F, Lee CM, Lear S, Shaw J, Lam TH, Caterson I, Azizi F, Patel J, Suriyawongpaisal P, Oh SW, Kang JH, Gill T, Zimmet P, James PT, Woodward M. Waist circumference thresholds provide an accurate and widely applicable method for the discrimination of diabetes. Diabetes Care 2007;30(12):3116-8.
  190. O'Dea K, Rowley KG, Brown A. Diabetes in Indigenous Australians: possible ways forward. Med J Aust 2007;186(10):494-5.
  191. Ooi EM, Watts GF, Barrett PH, Chan DC, Clifton PM, Ji J, Nestel PJ. Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndrome. Asia Pac J Clin Nutr 2007;16(4):624-31.
  192. Oro C, Qian H, Thomas WG. Type 1 angiotensin receptor pharmacology: signaling beyond G proteins. Pharmacol Ther 2007;113(1):210-226.
  193. Ott C, Schwarz T, Hilgers KF, Kreutz R, Schlaich MP, Schmieder RE. Left-ventricular structure and function are influenced by angiotensinogen gene polymorphism (-20 A/C) in young male patients. Am J Hypertens 2007;20(9):974-80.
  194. Ott C, Titze SI, Schwarz TK, Kreutz R, Hilgers KF, Schmidt BM, Schlaich MP, Schmieder RE. High sodium intake modulates left ventricular mass in patients with G expression of +1675 G/A angiotensin II receptor type 2 gene. J Hypertens 2007;25(8):1627-32.
  195. Pandian JD, Srikanth V, Read SJ, Thrift AG. Poverty and stroke in India: a time to act. Stroke 2007;38(11):3063-9.
  196. Paul SL, Srikanth VK, Thrift AG. The large and growing burden of stroke. Curr Drug Targets 2007;8(7):786-93.
  197. Peacock AJ, Murphy NF, McMurray JJ, Caballero L, Stewart S. An epidemiological study of pulmonary arterial hypertension. Eur Respir J 2007;30(1):104-9.
  198. Pedersen BK, Febbraio MA. Point: Interleukin-6 does have a beneficial role in insulin sensitivity and glucose homeostasis. J Appl Physiol 2007;102(2):814-6.
  199. Pepe S, Marasco SF, Haas SJ, Sheeran FL, Krum H, Rosenfeldt FL. Coenzyme Q10 in cardiovascular disease. Mitochondrion 2007;7 Suppl 1:S154-67.
  200. Racunica TL, Szramka M, Wluka AE, Wang Y, English DR, Giles GG, O'Sullivan R, Cicuttini FM. A positive association of smoking and articular knee joint cartilage in healthy people. Osteoarthritis Cartilage 2007;15(5):587-90.
  201. Racunica TL, Teichtahl AJ, Wang Y, Wluka AE, English DR, Giles GG, O'Sullivan R, Cicuttini FM. Effect of physical activity on articular knee joint structures in community-based adults. Arthritis Rheum 2007;57(7):1261-8.
  202. Reti NG, Lappas M, Huppertz B, Riley C, Wlodek ME, Henschke P, Permezel M, Rice GE. Effect of high oxygen on placental function in short-term explant cultures. Cell Tissue Res 2007;328(3):607-16.
  203. Reti NG, Lappas M, Riley C, Wlodek ME, Permezel M, Walker S, Rice GE. Why do membranes rupture at term? Evidence of increased cellular apoptosis in the supracervical fetal membranes. Am J Obstet Gynecol 2007;196(5):484.e1-10.
  204. Ritchie RH, Quinn JM, Cao AH, Drummond GR, Kaye DM, Favaloro JM, Proietto J, Delbridge LM. The antioxidant tempol inhibits cardiac hypertrophy in the insulin-resistant GLUT4-deficient mouse in vivo. J Mol Cell Cardiol 2007;42(6):1119-28.
  205. Roberts-Thomson KC, Kistler PM, Haqqani HM, McGavigan AD, Hillock RJ, Stevenson IH, Morton JB, Vohra JK, Sparks PB, Kalman JM. Focal atrial tachycardias arising from the right atrial appendage: electrocardiographic and electrophysiologic characteristics and radiofrequency ablation. J Cardiovasc Electrophysiol 2007;18(4):367-72.
  206. Rogers SL, Magliano DJ, Levison DB, Webb K, Clarke PJ, Grobler MP, Liew D. A dose-specific meta-analysis of lipid changes in randomized controlled trials of atorvastatin and simvastatin. Clin Ther 2007;29(2):242-52.
  207. Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong JY, Watts GF. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. J Hum Hypertens 2007;21(4):297-306.
  208. Rutherford S, Cai G, Lopez-Alvarenga JC, Kent JW, Voruganti VS, Proffitt JM, Curran JE, Johnson MP, Dyer TD, Jowett JB, Bastarrachea RA, Atwood LD, Goring HH, Maccluer JW, Moses EK, Blangero J, Comuzzie AG, Cole SA. A chromosome 11q quantitative-trait locus influences change of blood-pressure measurements over time in Mexican Americans of the San Antonio Family Heart Study. Am J Hum Genet 2007;81(4):744-55.
  209. Santiago FS, Ishii H, Shafi S, Khurana R, Kanellakis P, Bhindi R, Ramirez MJ, Bobik A, Martin JF, Chesterman CN, Zachary IC, Khachigian LM. Yin Yang-1 inhibits vascular smooth muscle cell growth and intimal thickening by repressing p21WAF1/Cip1 transcription and p21WAF1/Cip1-Cdk4-cyclin D1 assembly. Circ Res 2007;101(2):146-55.
  210. Schlaich MP, Delles C, Schmieder RE. Involvement of endothelial mechanisms in L-arginine-induced alterations of renal haemodynamics in humans. J Hypertens 2007;25(7):1515-6.
  211. Schlaich MP, Lambert EA, Sobotka PA, Lambert GW, Esler MD. Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment. Hypertension 2007;49(5):e27.
  212. Schlaich MP, Lambert GW, Lambert EA, Esler MD. Letter by Schlaich et al regarding article, "Relationship between central sympathetic drive and magnetic resonance imaging determined left ventricular mass in essential hypertension". Circulation 2007;116(17):e416.
  213. Schlaich MP, Oehmer S, Schneider MP, Delles C, Schmidt BM, Schmieder RE. Effects of nitric oxide synthase inhibition and L-arginine on renal haemodynamics in young patients at high cardiovascular risk. Atherosclerosis 2007;192(1):155-60.
  214. Schlaich MP, Schmieder RE. Contribution of endothelial nitric oxide to blood pressure in humans. Hypertension 2007;49(5):e29.
  215. Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM. Renin-angiotensin system and cardiovascular risk. Lancet 2007;369(9568):1208-19.
  216. Schwarz M, Hagemeyer CE, Peter K, Bode C. Helping antibodies. Targeted antithrombotic and fibrinolytic therapy. Hamostaseologie 2007;27(5):360-2.
  217. Shaw J. Epidemiology of childhood Type 2 diabetes and obesity. Pediatr Diabetes 2007;8 Suppl 9:7-15.
  218. Shemesh T, Rowley KG, Jenkins A, Brimblecombe J, Best JD, O'Dea K. Differential association of C-reactive protein with adiposity in men and women in an Aboriginal community in northeast Arnhem Land of Australia. Int J Obes 2007;31(1):103-8.
  219. Shield K, Riley C, Quinn MA, Rice GE, Ackland ML, Ahmed N. alpha2beta1 integrin affects metastatic potential of ovarian carcinoma spheroids by supporting disaggregation and proteolysis. J Carcinog 2007;6(11).
  220. Showkathali R, Earley MJ, Gupta D, Alzetani M, Harris S, Kistler PM, Sporton SC, Schilling RJ. Current case mix and results of catheter ablation of regular supraventricular tachycardia: are we giving unrealistic expectations to patients? Europace 2007;9(11):1064-8.
  221. Sicree R, Shaw J. Type 2 diabetes: An epidemic or not, and why it is happening. Diabetes Metabolic Syndrome Clin Res Rev 2007;1(2):75-81.
  222. Simmons D, Eaton S, Shaw J, Zimmet P. Self-reported past gestational diabetes mellitus as a risk factor for abnormal glucose tolerance among Australian women. Diabetes Care 2007;30(9):2293-5.
  223. Singh R, Zimmet P, Shaw J. Mental health, antipsychotics and hyperglycaemia. Diabetes Metabolic Syndrome Clin Res Rev 2007;1(3):209-24.
  224. Söderberg S, Zimmet P, Tuomilehto J, Chitson P, Gareeboo H, Alberti KG, Shaw JE. Leptin predicts the development of diabetes in Mauritian men, but not women: a population-based study. Int J Obes 2007;31(7):1126-33.
  225. Southgate RJ, Neill B, Prelovsek O, El-Osta A, Kamei Y, Miura S, Ezaki O, McLoughlin TJ, Zhang W, Unterman TG, Febbraio MA. FOXO1 regulates the expression of 4E-BP1 and inhibits mTOR signaling in mammalian skeletal muscle. J Biol Chem 2007;282(29):21176-86.
  226. Stewart S. "You'll never walk alone": key challenges for the profession of cardiovascular nursing. Eur J Cardiovasc Nurs 2007;6(1):1-2.
  227. Stewart S. Stopping heart failure in its tracks. Eur J Heart Fail 2007;9(2):118-9.
  228. Stoll P, Bassler N, Hagemeyer CE, Eisenhardt SU, Chen YC, Schmidt R, Schwarz M, Ahrens I, Katagiri Y, Pannen B, Bode C, Peter K. Targeting ligand-induced binding sites on GPIIb/IIIa via single-chain antibody allows effective anticoagulation without bleeding time prolongation. Arterioscler Thromb Vasc Biol 2007;27(5):1206-12.
  229. Straub A, Breuer M, Wendel HP, Peter K, Dietz K, Ziemer G. Critical temperature ranges of hypothermia-induced platelet activation: Possible implications for cooling patients in cardiac surgery. Thromb Haemost 2007;97(4):608-16.
  230. Sugiyama T, Salmon J, Dunstan DW, Bauman AE, Owen N. Neighborhood walkability and TV viewing time among Australian adults. Am J Prev Med 2007;33(6):444-9.
  231. Sviridov D, Nestel P, Watts G. Statins and metabolism of high density lipoprotein. Cardiovasc Hematol Agents Med Chem 2007;5(3):215-21.
  232. Sviridov D, Nestel PJ. Genetic factors affecting HDL levels, structure, metabolism and function. Curr Opin Lipidol 2007;18(2):157-63.
  233. Szollosi I, Krum H, Kaye D, Naughton MT. Sleep apnea in heart failure increases heart rate variability and sympathetic dominance. Sleep 2007;30(11):1509-14.
  234. Tan AL, Forbes JM, Cooper ME. AGE, RAGE, and ROS in diabetic nephropathy. Semin Nephrol 2007;27(2):130-43.
  235. Tang AL, Shah NP, Wilcox G, Walker KZ, Stojanovska L. Fermentation of calcium-fortified soymilk with Lactobacillus: effects on calcium solubility, isoflavone conversion, and production of organic acids. J Food Sci 2007;72(9):M431-6.
  236. Tapp RJ, Balkau B, Shaw JE, Valensi P, Cailleau M, Eschwege E; DESIR Study Group. Association of glucose metabolism, smoking and cardiovascular risk factors with incident peripheral arterial disease: the DESIR study. Atherosclerosis 2007;190(1):84-9.
  237. Teichtahl AJ, Parkins K, Hanna F, Wluka AE, Urquhart DM, English DR, Giles GG, Cicuttini FM. The relationship between the angle of the trochlear groove and patella cartilage and bone morphology--a cross-sectional study of healthy adults. Osteoarthritis Cartilage 2007;15(10):1158-62.
  238. Tesch GH, Allen TJ. Rodent models of streptozotocin-induced diabetic nephropathy. Nephrology 2007;12(3):261-6.
  239. Thomas M, Weekes AJ, Thomas MC. The management of diabetes in Indigenous Australians in the primary care setting. BMC Public Health 2007;7(1):303.
  240. Thomas MC, Nestel PJ. Management of dyslipidaemia in patients with Type 2 diabetes in Australian primary care. Med J Aust 2007;186(3):128-30.
  241. Thomas MC. Anemia in diabetes: marker or mediator of microvascular disease? Nat Clin Pract Nephrol 2007;3(1):20-30.
  242. Thomas MC; Caring for Australians with Renal Impairment (CARI). The CARI guidelines. Prevention of progression of kidney disease: early detection of patients with kidney disease. Nephrology 2007;12 Suppl 1:S37-40.
  243. Thomas MC; Caring for Australians with Renal Impairment (CARI). The CARI guidelines. Prevention of progression of kidney disease: early referral of patients with pre-end-stage kidney disease. Nephrology 2007;12 Suppl 1:S41-3.
  244. Thomas MC; Caring for Australians with Renal Impairment (CARI). The CARI guidelines. Prevention of progression of kidney disease: regular and frequent follow-up of patients with pre-end-stage kidney disease. Nephrology 2007;12 Suppl 1:S44-5.
  245. Thomas MC; Caring for Australians with Renal Impairment (CARI). The CARI guidelines. Prevention of progression of kidney disease: pre-dialysis education for patients with chronic kidney disease. Nephrology 2007;12 Suppl 1:S46-8.
  246. Thomas MC; Caring for Australians with Renal Impairment (CARI). The CARI guidelines. Prevention of progression of kidney disease: weight reduction in obese patients with chronic kidney disease. Nephrology 2007;12 Suppl 1:S49-51.
  247. Thomas MC; Caring for Australians with Renal Impairment (CARI). The CARI guidelines. Prevention of progression of kidney disease: autosomal-dominant polycystic kidney disease R Nephrology 2007 12 Suppl 1 S52-6.
  248. Thompson DR, Stewart S. Handmaiden or right-hand man: is the relationship between doctors and nurses still therapeutic? Int J Cardiol 2007;118(2):139-40.
  249. Thompson DR, Watson R, Stewart S. Nursing and midwifery: time for an amicable divorce? Int J Nurs Stud 2007;44(4):523-4.
  250. Thornblad TA, Elliott KS, Jowett J, Visscher PM. Prioritization of positional candidate genes using multiple web-based software tools. Twin Res Hum Genet 2007;10(6):861-70.
  251. Thrift AG, Hayman N. Aboriginal and Torres Strait Islander peoples and the burden of stroke. Int J Stroke 2007;2(1):57-9.
  252. Tibazarwa KB, Ntyintyane L, Stewart S, Wilkinson D, Sliwa K. Cardiovascular screening and hypertension in an African population : heart awareness day in Soweto. Cardiovasc J Afr 2007;18(3 Suppl):S29-31.
  253. Tikellis G, Wang JJ, Tapp R, Simpson R, Mitchell P, Zimmet PZ, Shaw J, Wong TY. The relationship of retinal vascular calibre to diabetes and retinopathy: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study. Diabetologica 2007;50(11):2263-71.
  254. Tu Y, Wu W, Wu T, Cao Z, Wilkins R, Toh BH, Cooper ME, Chai Z. Antiproliferative autoantigen CDA1 transcriptionally up-regulates p21Waf1/Cip1 by activating p53 and MEK/ERK1/2 MAPK pathways. J Biol Chem 2007;282(16):11722-31.
  255. Turner N, Bruce CR, Beale SM, Hoehn KL, So T, Rolph MS, Cooney GJ. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. Diabetes 2007;56(8):2085-92.
  256. Vaddadi G, Lambert E, Corcoran SJ, Esler MD. Postural syncope: mechanisms and management. Med J Aust 2007;187(5):299-304.
  257. van der Merwe J, Leong JY, Kaye D, Opat S, Bergin PJ, Taylor AJ, Rosenfeldt F. Antioxidant therapy for severe cardiac failure Induced by iron overload secondary to dyserythropoietic anaemia. Heart Lung Circ 2007;16(5):394-7.
  258. Venardos KM, Kaye DM. Myocardial ischemia-reperfusion injury, antioxidant enzyme systems, and selenium: a review. Curr Med Chem 2007;14(14):1539-49.
  259. von zur Muehlen C, von Elverfeldt D, Bassler N, Neudorfer I, Steitz B, Petri-Fink B, Hofmann H, Bode C, Peter K. Superparamagnetic iron oxide binding and uptake as imaged by magnetic resonance is mediated by the integrin receptor Mac-1 (CD11b/CD18): implications on imaging of atherosclerotic plaques. Atherosclerosis 2007;193(1):102-11.
  260. Vorum H, Østergaard M, Rice GE, Honoré B, Bek T. Identification of differentially regulated proteins in a patient with Leber's Congenital Amaurosis--a proteomic study. Proteome Sci 2007;5:1-9.
  261. Walker KZ, O'Dea K. Monounsaturated fat rich diet prevents central body fat distribution and decreases postprandial adiponectin expression induced by a carbohydrate-rich diet in insulin-resistant subjects: response to Paniagua et al. Diabetes Care 2007;30(11):e122.
  262. Wang JM. Selenoprotein S1: a novel inflammatory gene. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2007;32(5):723-5.
  263. Wang Y, Hodge AM, Wluka AE, English DR, Giles GG, O'Sullivan R, Forbes A, Cicuttini FM. Effect of antioxidants on knee cartilage and bone in healthy, middle-aged subjects: a cross-sectional study. Arthritis Res Ther 2007;9(4):R66.
  264. Wang Z, Rowley K, Best J, McDermott R, Taylor M, O'Dea K. Hemostatic factors in Australian Aboriginal and Torres Strait Islander populations. Metabolism 2007;56(5):629-35.
  265. Wang Z, Rowley K, Wang Z, Piers L, O'Dea K. Anthropometric indices and their relationship with diabetes, hypertension and dyslipidemia in Australian Aboriginal people and Torres Strait Islanders. Eur J Cardiovasc Prev Rehabil 2007;14(2):172-8.
  266. Weekes AJ, Thomas MC. The use of oral antidiabetic agents in primary care. Aust Fam Physician 2007;36(6):477-80.
  267. Wein L, Wein S, Haas SJ, Shaw J, Krum H. Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials. Arch Intern Med 2007;167(14):1476-86.
  268. White AJ, Duffy SJ, Walton AS, Ng JF, Rice GE, Mukherjee S, Shaw JA, Jennings GL, Dart AM, Kingwell BA. Matrix metalloproteinase-3 and coronary remodelling: implications for unstable coronary disease. Cardiovasc Res 2007;75(4):813-20.
  269. Wong C, Marwick TH. Obesity cardiomyopathy: diagnosis and therapeutic implications. Nat Clin Pract Cardiovasc Med 2007;4(9):480-90.
  270. Wong C, Marwick TH. Obesity cardiomyopathy: pathogenesis and pathophysiology. Nat Clin Pract Cardiovasc Med 2007;4(8):436-43.
  271. Woodcock EA. Roles of 1A- and 1B-adrenoceptors in heart: insights from studies of genetically modified mice. Clin Exp Pharmacol Physiol 2007;34(9):884-8.
  272. Woollard KJ, Chin-Dusting J. Therapeutic targeting of P-selectin in atherosclerosis. Inflamm Allergy Drug Targets 2007;6(1):69-74.
  273. Worthley MI, Holmes AS, Willoughby SR, Kucia AM, Heresztyn T, Stewart S, Chirkov YY, Zeitz CJ, Horowitz JD. The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes mediation by superoxide production, resolution with intensive insulin administration. J Am Coll Cardiol 2007;49(3):304-10.
  274. Xu Q, Ming ZQ, Dart AM, Du XJ. Optimizing dosage of ketamine and xylazine in murine echocardiography. Clin Exp Pharmacol Physiol 2007;34(5):499-507.
  275. Yan BP, Gurvitch R, Duffy SJ, Clark DJ, Sebastian M, New G, Warren R, Lefkovits J, Lew R, Brennan AL, Reid C, Andrianopoulos N, Ajani AE. An evaluation of octogenarians undergoing percutaneous coronary intervention from the Melbourne Interventional Group registry. Catheter Cardiovasc Interv 2007;70(7):928-36.
  276. Yang Z, Venardos K, Jones E, Morris BJ, Chin-Dusting J, Kaye D. Identification of a novel polymorphism in the 3'UTR of the L-arginine transporter gene SLC7A1. Contribution to hypertension and endothelial dysfunction. Circulation 2007;115(10):1269-74.
  277. Yeoh GC, Ernst M, Rose-John S, Akhurst B, Payne C, Long S, Alexander W, Croker B, Grail D, Matthews VB. Opposing roles of gp130-mediated STAT-3 and ERK-1/2 signaling in liver progenitor cell migration and proliferation. Hepatology 2007;45(2):486-94.
  278. Young IR, Rice GE, Palliser HK, Ayhan M, Dellios NL, Hirst JJ. Identification of bactenecin-1 in cervicovaginal fluid by two-dimensional electrophoresis in an ovine model of preterm labour. Proteomics 2007;7(2):281-8.
  279. Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT, Roberts AB, Neilson EG, Sayegh MH, Izumo S, Kalluri R. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 2007;13(8):952-61.
  280. Zhang L, Pu K, Chai Z, Dixon JB. Family history of coronary heart disease is associated with a higher incidence of nonalcoholic fatty liver disease: central obesity the likely link. Obes Res Clin Pract 2007;1(2):125-31.
  281. Zhang W-Z, Lang C, Kaye DM. Determination of plasma free 3-nitrotyrosine and tyrosine by reversed-phase liquid chromatography with 4-fluoro-7-nitrobenzofurazan derivitization. Biomed Chromatogr 2007;21(3):273-8.
  282. Zimmet P, Alberti G, Kaufman F, Tajima N, Silink M, Arslanian S, Wong G, Bennett P, Shaw J, Caprio S; International Diabetes Federation Task Force on Epidemiology and Prevention of Diabetes. The metabolic syndrome in children and adolescents. Lancet 2007;369(9579):2059-61.
  283. Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, Wong G, Bennett P, Shaw J, Caprio S; IDF Consensus Group. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes 2007;8(5):299-306.
  284. Zimmet P. Diabesity - the biggest epidemic in human history. MedGenMed 2007;9(3):39.
  285. Zimmet P. The metabolic syndrome: does it exist? MedGenMed 2007;9(3):51.
  286. Zirlik A, Maier C, Gerdes N, MacFarlane L, Soosairajah J, Bavendiek U, Ahrens I, Ernst S, Bassler N, Missiou A, Patko Z, Aikawa M, Schonbeck U, Bode C, Libby P, Peter K. CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1. Circulation 2007;115(12):1571-80.


  1. Cohen M (ed). Handbook of Diabetes Management. 8th edition, 2007. ISBN 9780646070487. International Diabetes Institute and Servier Laboratories, Melbourne.
  2. Stewart S. A Self-fulfilling Prophecy: Building a Successful Career in Health Research. 2007. ISBN 9780470060711. Wiley & Sons Ltd, UK.
  3. Stewart S, Strange G. A Clinician's Guide to Pulmonary Arterial Hypertension, 2nd edition. 2007. ISBN 9781841846651. Informa Healthcare, UK.

Book chapters

  1. Barton DA, Joubert L, Alvarenga M, Norrie P, Brenchley C. Affective disorders. In: Meadows G, Singh B, Grigg M (eds) Mental Health in Australia: Collaborative Community Practice, 2nd edition. 2007. Oxford University Press, USA. pp509-33.
  2. Barton DA, Joubert L, Alvarenga M, Norrie P, Brenchley C. Anxiety disorders. In: Meadows G, Singh B, Grigg M (eds) Mental Health in Australia: Collaborative Community Practice, 2nd edition. 2007. Oxford University Press, USA. pp493-8.
  3. Brown A, Walsh W, Ring I. Coronary heart disease. In: Couzos S, Murray R (eds) Aboriginal Primary Health Care: An Evidence-based Approach, 3rd edition. 2007. Oxford University Press, Melbourne. pp483-520.
  4. Chapman L. Atypical psychotic agents. In: Cohen M (ed) Handbook of Diabetes Management, 8th edition. 2007. International Diabetes Institute and Servier Laboratories, Melbourne. pp125-6.
  5. Cleland SJ, Shaw J. Prevention of diabetes as a means of preventing cardiovascular disease BC In: Fisher M, McMurray JJ (eds). Diabetic Cardiology. 2007. John Wiley & Sons, UK. pp240-57.
  6. Dunstan DW, Daly RM. Exercise in older adults with diabetes. In: Munshi MN, Lipsitz LA (eds) Geriatric Diabetes. 2007. Informa Healthcare, USA. pp 301-16.
  7. Eikelis N. Neurobiology of obesity. In: Bagchi D, Preuss HG (eds). Obesity: Epidemiology, Pathophysiology, and Prevention. 2007. CRC Press, USA. pp81-92.
  8. Hagger V. Diabetes education. In: Cohen M (ed) Handbook of Diabetes Management, 8th edition. 2007. International Diabetes Institute and Servier Laboratories, Melbourne. pp127-32.
  9. Lambert GW, Dawood T. Psychosomatic heart disease: role of sympathetic and sympathoadrenal processes. In: Fink G (ed) Encyclopedia of Stress, 2nd edition. 2007. Academic Press, Elsevier, UK. pp. 292-6.
  10. Lancaster GI, Febbraio MA. Mechanisms of stress-induced cellular HSP72 release . In: Asea AA, De Maio A (eds) Heat Shock Proteins: Potent Mediators of Inflammation and Immunity. 2007. Springer, The Netherlands. pp31-38.
  11. Morrissey M, Pe-Pua R, Brown A, Latif A. Culture as a determinant of Aboriginal health. In: Anderson I, Baum F, Bentley M (eds) Beyond Bandaids: Exploring the Underlying Social Determinants of Aboriginal Health. Papers from the Social Determinants of Aboriginal Health Workshop, Adelaide, July 2004. 2007. Cooperative Research Centre for Aboriginal Health, Darwin. pp239-54.
  12. Shaw JE. Diagnosis of diabetes. In: Cohen M (ed) Handbook of Diabetes Management, 8th edition. 2007. International Diabetes Institute and Servier Laboratories, Melbourne. pp13-5.
  13. Shaw JE. Introduction. In: Cohen M (ed) Handbook of Diabetes Management, 8th edition. 2007. International Diabetes Institute and Servier Laboratories, Melbourne. pp1-11.
  14. Shaw JE. Sleep apnea. In: Cohen M (ed) Handbook of Diabetes Management, 8th edition. 2007. International Diabetes Institute and Servier Laboratories, Melbourne. p123.
  15. Smith DJ, Barton D, Joubert L Psychological and social influences on male sexual function. In: Kandeel FR (ed) Male Sexual Dysfunction Pathophysiology and Treatment. 2007. Informa Healthcare, USA. pp85-94.
  16. Stapleton JM, Thrift AG, Saling MM, Srikanth VK. How useful are the MMSE and IQCODE in diagnosing cognitive impairment and dementia in stroke patients? In: Vellas B, Fitten LJ, Feldman H, Giacobini E, Grundman M, Winblad B, Kurz A (eds) Research and Practice in Alzheimer's Disease, Vol 12. 2007. Serdi Publisher, France. pp117-21.
  17. Sviridov D, Bukrinsky MI, Kingwell BA, Hoy J. HDL in health and disease: effects of exercise and HIV infection on HDL metabolism. In: Fielding CJ (ed) High-Density Lipoproteins: From Basic Biology to Clinical Aspects. 2007. Wiley-VCH, Germany. pp355-74.
  18. Talman P, Reid CM, Mathers S. The function of registries in motor neurone disease. In: Kiernan MC (ed) The Motor Neurone Disease Handbook. 2007. Australasian Medical Publishing Company, Sydney.
  19. Waldron A. Nutrition. In: Cohen M (ed) Handbook of Diabetes Management, 8th edition. 2007. International Diabetes Institute and Servier Laboratories, Melbourne. p74.

Support us

With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.

Find out more